TORONTO, June 14, 2022 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (the “ Company” or “Field Trip“), a global leader in the development and delivery of psychedelic therapies, announced today that it has agreed to increase its participation in the concurrent financing, in support of, and in connection with, the spin-out of its clinics business to Field Trip Health &

Source

Previous articleSmall Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022
Next articleMindmed Announces Voting Results for Annual General and Special Meeting